Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Prepares For Year-End US Bevacizumab Launch

Sep 27 2019

• By Aidan Fry

Jumping — Pfizer will enter 2020 on the back of launching its Zirabev becacizumab biosimilar in the US on 31 December • Source: Shutterstock

Related Content

US Insurer United Rewards Amgen’s Early Entry With Bevacizumab And Trastuzumab

Aug 21 2019

Pfizer Plans For Three Biosimilar Launches In Japan and US This Year

May 03 2019

Related Companies

Pfizer Inc.

Amgen, Inc.

Additional Topics

United States Biosimilars Launches Intellectual Property Biologics Commercial Companies Legal Issues Cancer BioPharmaceutical

More from Biosimilars

More from Products

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.